Teesalu Kaupo, Agardh Daniel, Panarina Marina, Utt Meeme, Uibo Oivi, Uibo Raivo
Immunology group, Department of General and Molecular Pathology, University of Tartu, Tartu, Estonia.
Clin Chim Acta. 2009 May;403(1-2):37-41. doi: 10.1016/j.cca.2009.01.006.
Serum IgA antibodies against tissue transglutaminase (tTG) are reliable markers for celiac disease (CD), still the diagnostic performance of anti-tTG immunoassays can be improved. A novel ELISA, using fibronectin (FN) as tTG binding protein, was evaluated for the detection of anti-tTG antibodies in CD.
Sera from 173 children with untreated CD and 97 controls were analyzed for IgA, IgG, and IgM anti-tTG antibodies with ELISA using human recombinant tTG with or without FN.
The areas under the ROC (receiver operating characteristic) curves were significantly higher for FN/tTG ELISA compared to tTG ELISA for IgG (0.930 versus 0.809; p < 0.001) and IgM (0.850 versus 0.811; p = 0.019), but not for IgA (0.977 versus 0.970; p = 0.356), respectively. At the fixed diagnostic specificity (100% for IgA and IgM, 99% for IgG), the sensitivity of all three FN/tTG ELISA (92.5% for IgA, 60.7% for IgG, 50.3% for IgM) exceeded those obtained in tTG ELISA (89.0% for IgA, 48.6% for IgG, 38.7% for IgM; p < 0.05). The combined use of IgA- and IgG-FN/tTG ELISA resulted in 95.4% sensitivity and 99.0% specificity for CD.
Using FN to bind tTG improves the diagnostic performance of solid phase anti-tTG antibody assays for childhood CD.
血清抗组织转谷氨酰胺酶(tTG)IgA抗体是乳糜泻(CD)的可靠标志物,但抗tTG免疫测定的诊断性能仍可提高。一种使用纤连蛋白(FN)作为tTG结合蛋白的新型酶联免疫吸附测定(ELISA),用于检测CD患者血清中的抗tTG抗体。
采用人重组tTG,有无FN参与,用ELISA分析173例未经治疗的CD患儿和97例对照的血清中IgA、IgG和IgM抗tTG抗体。
与tTG ELISA相比,FN/tTG ELISA检测IgG(0.930对0.809;p<0.001)和IgM(0.850对0.811;p=0.019)的受试者工作特征(ROC)曲线下面积显著更高,但检测IgA时(0.977对0.970;p=0.356)并非如此。在固定诊断特异性(IgA和IgM为100%,IgG为99%)时,所有三种FN/tTG ELISA的敏感性(IgA为92.5%,IgG为60.7%,IgM为50.3%)均超过tTG ELISA(IgA为89.0%,IgG为48.6%,IgM为38.7%;p<0.05)。联合使用IgA-和IgG-FN/tTG ELISA诊断CD的敏感性为95.4%,特异性为99.0%。
使用FN结合tTG可提高固相抗tTG抗体检测对儿童CD的诊断性能。